The vacancy against the covid-19 of AstraZeneca has an efficiency of 79% to prevent infestation and does not increase the risk of blood clots, dijo the biotechnology company the lunes, lieu its phase 3 efficiency tests in the United States.
The vacancy will also be effective at 80% for the mayor of 65 years, dijo. Various lands habían suspended the administration of the pharmacy to major persons debited to the lack of data between the participants of advanced eda in previous aisles.
Phase 3 studies in the United States of the country unpacked by AstraZeneca and the University of Oxford will employ 32,449 people, each of whom will receive a dose, according to a statement from the pharmaceutical company.
The surveys conducted by an independent team hallaron that do not have a mayor risk of thunderstorms between the 21 583 participants that receive at least one dose, the communicator signals.
“These reconfirmed data are prevalent results observed in AZD1222 studies in all adult populations, but it is very emotional to see first-time results of similar efficacy and persons over 65 years”, said Ann Falsey, Professor of the Faculty of Medicine the University of Rochester and one of the investigators conducting the studies.
“This analysis recognizes the AstraZeneca vaccine against covid-19 as one of the vaccination options that are needed, and offers confidence that all adults can benefit from protection against the virus,” he said.
Gran Bretaña authorizes the base dose in individual results of studies in Gran Bretaña, Brazil and South Africa which have an efficiency of 70%. But their results were affected by a manufacturing failure that resulted in some participants receiving open media doses at their first injection, an error that investigators did not recognize at an early stage.
Después read more dudas about the protection that overreach to the mayors and how much time to hope between the dosages. Some European countries, such as Germany, France and Belgium, avoid on a principle of seniority and only change politics when appearing new dates that suggest that both protect the mayors.
More than a dozen dozen countries in Europe temporarily suspended the staff of AstraZeneca’s vacancy last week in reports that the association has been accused of collusion. The Jueves, the European Medicines Agency, concluded an investigation into which the vaccine did not increase the risk of blood clots in general, even though it could not be related to the classes of very few common clones.
Preparation for emergency authorization application
An FDA assessment committee will hold a public debate on the tests that support the pharmacy before deciding whether to allow the use of vaccine.
The hopefuls of the results of the study study will have the hope of clearing up some of the confusion about how well the job actually works.
Julian Tang, virologist at the University of Leicester and who did not take part in the study, described it as “good news” for the AstraZeneca showcase.
“Although the papel can perform less effectively, the AZ vaccine is much more difficult and much easier to carry and transport than the Pfizer and Modern vaccines that are currently used in the United States,” said Tang, quoted by the AP.
